Buprenorphine (CAM2038) trial for the treatment of opioid dependent patients with chronic pain.

Trial Profile

Buprenorphine (CAM2038) trial for the treatment of opioid dependent patients with chronic pain.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 17 May 2016

At a glance

  • Drugs Buprenorphine (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 17 May 2016 According to a Camurus media release, the company anticipates the results of this trial in the fourth quarter of 2016.
    • 22 Feb 2016 According to Braeburn Pharmaceuticals media release, first patients have been dosed in this trial.
    • 22 Feb 2016 According to Braeburn Pharmaceuticals media release, status changed from planning to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top